Researchers outline biological mechanisms of breast cancer brain metastasis, highlighting key molecular pathways and the role of the brain microenvironment. The review also discusses emerging therapeutic approaches and calls for cross-disciplinary collaboration to improve outcomes.
Research suggests m⁶A modification regulates oncogenic pathways, immune evasion, and metabolic reprogramming in cancer. Dysregulation of m⁶A drives cancer hallmarks like uncontrolled proliferation and metastasis.
Chronic wounds like diabetic foot ulcers and pressure ulcers are driven by persistent inflammation and immune dysregulation. Emerging immunomodulatory strategies aim to restore immune balance and promote healing.
Reactive oxygen species (ROS) homeostasis is essential for cellular survival and physiological functions. The review discusses its biological significance, potential clinical applications, and regulatory mechanisms underlying ROS homeostasis. Dysregulation of ROS homeostasis is a common pathogenic mechanism driving disease development.
Recent discoveries in breast cancer biology highlight the potential of targeted therapies and molecularly guided treatment approaches. The review discusses various treatments, including monoclonal antibodies and immunotherapies, as well as challenges in treating triple-negative and HER2-positive breast cancers.
Researchers have developed lipid-based nanoplatforms (LBNCs) to overcome liver disease treatment barriers, including low drug accumulation and side effects. LBNCs exhibit biocompatibility, versatile drug-loading capacity, and tunable targeting, improving therapeutic effects on fatty liver and HCC.
Researchers have developed vitamin-engineered nanoplatforms that can overcome tumor heterogeneity and therapeutic resistance. These platforms integrate immunomodulation, precision drug delivery, and diagnostic capabilities, enabling targeted therapy and early detection of cancer.
The WNT signaling pathway is a double-edged sword in human health, promoting tumor growth and resistance to therapy while offering therapeutic targets. Recent advances in understanding this pathway aim to harness it for cancer treatment, with focus on improving drug specificity and combination therapies.
Recent review article highlights how single-cell multi-omics technologies are deciphering the intricate heterogeneity of biliary tract cancers. Researchers can now analyze genetic, transcriptomic, and epigenetic facets of individual cells within a tumor.
Recent discoveries on the molecular regulation of cholesterol metabolism have far-reaching implications for human diseases. Four interconnected modules of cholesterol metabolism are outlined, including hepatic de novo synthesis, intestinal absorption, and reverse transport via HDL.
Researchers found OGT expression is higher in MASLD-HCC tissues, promoting tumor growth. OGT modifies PTEN, impairing its function and activating the PI3K/Akt pathway.
DDX17 promotes HCC metastasis via the β-catenin/TCF4 pathway, inducing EMT and enhancing migration/invasion. The β-catenin/TCF4/DDX17 feedback loop is essential for HCC dissemination.
Researchers are exploring bioelectrical impedance technology to monitor neurological diseases like stroke, epilepsy, and brain tumors. The technology captures subtle changes linked to cellular metabolism and pathological processes, enabling clinicians to track disease progression with minimal risk.
Researchers have developed a new platform for investigating tumor metastasis using CTC-derived organoids. These organoids provide an in-depth model for analyzing CTC behavior, including interactions with the tumor microenvironment and drug resistance mechanisms.
Researchers found that colorectal cancer cells stimulate cancer-associated fibroblasts to produce collagen through TGF-β1-induced de novo glycine synthesis. PHGDH is identified as a potential therapeutic target for treating colorectal cancer.
The Cu2+-coordinated NLG919 nanoplatform induces immunogenic cell death and inhibits indoleamine 2,3-dioxygenase-1 to activate antitumor immunity. It also reverses the tumor microenvironment by blocking IDO1 inhibition.
A multicenter study found that preoperative Mini-Cog scores can predict postoperative delirium risk in elderly patients. The study used a mendelian randomization analysis to identify genetic variants associated with cognitive performance, suggesting that preoperative screening may help identify high-risk patients.
A comprehensive review highlights Gemini surfactants as a promising alternative to viral vectors in gene therapy delivery. The review outlines key structural elements governing delivery performance and complex stability, as well as next-gen upgrades such as cancer-homing peptides and biomimetic coatings.
The review critically examines anti-TGFβ therapies for cancer treatment, highlighting the importance of targeting specific epitopes to mitigate off-target toxicity. It suggests implementing intermittent dosing schedules or optimally timed interventions to alleviate toxicity without compromising efficacy.
Researchers identified a novel homozygous nonsense mutation in DLGAP5 responsible for human female infertility. The mutation led to abnormal oocyte maturation and impaired embryo development, with no cleavage embryos developing into blastocysts.
Mitochondria are responsible for producing cellular energy and maintaining homeostasis, but dysfunction has been implicated in neurodegenerative disorders, cardiovascular diseases, metabolic disorders, cancer, and aging. Targeted therapies are being explored to restore mitochondrial function and reduce oxidative stress.
Dysregulation of phosphatases modulates various signaling pathways, including RAS/MAPK, PI3K, HIPPO, and JAK/STAT. This review highlights the tumour suppressive, tumour promoting, and context-dependent activities of phosphatases, as well as their roles in reshaping the tumour microenvironment through exosomal miRNA secretion.
Lysine lactylation is a novel post-translational modification connecting cellular metabolism with gene expression and protein function. Non-histone Kla has diverse roles in inflammation, DNA repair, cancer metabolism, and immune signaling.
The study presents ImmunoCheckDB, a web platform that bridges a critical gap in existing resources by enabling pan-cancer exploration of immune checkpoint inhibitor therapies through combined meta-analytical and multiomic approaches. It curates 173 studies involving 93,234 individuals across 18 cancer types and 30 ICI regimens.
A recent study found that ATG5-mediated autophagy in alveolar epithelial cells protects against Pseudomonas infection by preventing inflammation. The mechanism involves the formation of gasdermin D pores, which amplify inflammation through macrophage activation.
The mitochondrial ribosomal protein family (MRPs) is dysregulated in various cancers, influencing tumor initiation and progression. MRPs regulate metabolic reprogramming of immune cells within the tumor microenvironment, affecting growth, migration, invasion, and chemoresistance.
A groundbreaking review identifies the skin as a central hub for systemic inflammation regulation, linking it to multiple organs through bidirectional crosstalk. The study reveals IL-17A as a master regulator of multi-organ crosstalk, driving various diseases simultaneously.
Researchers identified five adenosine phosphate signaling subtypes in melanoma, associated with immune activation and improved response to anti-PD-1/PD-L1 therapy. The Adenosine Phosphate Signaling Model predicts prognosis and immunotherapy outcomes, offering new biomarker and therapeutic strategies for solid tumors.
The review highlights three key regulatory layers of T-cell plasticity: cellular signals, metabolic reprogramming, and physical and biological factors. Innovative therapeutic strategies, such as immune checkpoint therapy and adoptive cell therapy, aim to restore T-cell function and enhance antitumor immunity.
DeepSeek-R1 has been shown to enhance clinical workflows, supporting diagnostic reasoning, treatment planning, and risk assessment. The model has also demonstrated promise in patient engagement and medical education, improving patient adherence and creating interactive educational cases.
Precision Delivery strategies aim to 'spatially couple' therapies with target cells in vivo, enhancing effectiveness while reducing adverse effects. The technology comprises three interconnected modules: targeted delivery, microenvironment modulation, and cellular interactions.
A new review article reveals the dynamic mechanisms of ROS regulating antigen processing and presentation, proposing combined immunotherapy strategies based on redox homeostasis regulation. Targeting redox homeostasis is a promising direction for enhancing tumor immunotherapy efficacy.
Breast cancer remains a significant health challenge worldwide, with nanotechnology offering a ray of hope. Nanoparticles improve diagnostic imaging, biomarker detection, and therapy by enhancing drug solubility, stability, and targeted delivery.
Researchers deciphered Amuc_1547, a gut bacterium's sialidase enzyme that breaks down mucins to acquire energy. The enzyme's unique mechanism reveals new paths for treating metabolic diseases like obesity and inflammatory bowel disease.
Researchers identified ADH4 as a key suppressor of HCC and found that silencing it increases tumor growth; forced ADH4 expression reverses oncogenic traits. RA production counteracts the Wnt/β-catenin signaling pathway, driving cellular proliferation.
Researchers identified fexofenadine as a potential Met-inhibitor that can overcome osimertinib resistance in NSCLC. The study found that fexofenadine enhances the anticancer effect of osimertinib in both laboratory and mouse models, making it a promising repurposed drug for treating NSCLC.
Recent studies have improved the diagnostic accuracy of CUP, surpassing 90%, with advancements in methodologies such as gene expression profiling. Site-specific therapies have shown significant benefits over empirical chemotherapy, leading to improved patient outcomes for those affected by this condition.
Researchers identified CSC characteristics, endogenous regulatory mechanisms, niche factors, and targeting strategies for digestive system tumors. Understanding CSCs is crucial for developing breakthrough treatments.
The article provides actionable insights into how educators can use AI tools like ChatGPT and adaptive learning systems to enhance traditional teaching methods. The guide emphasizes the importance of implementing AI with care, ensuring that human-led education remains a priority.
Researchers identified 11 cuproptosis-related genes and classified IDH1-mutant gliomas into two subtypes with distinct clinical outcomes. A risk model using FDX1/SLC31A1-based features demonstrated superior prognostic performance, providing insights for chemotherapy selection and treatment resistance.
The review delves into genetic, epigenetic, and molecular mechanisms driving tumor metastasis, highlighting the roles of chromosomal instability, epigenetic modifications, and tumor microenvironment interactions. It also discusses the impact of specific genetic mutations and RNA modifications on metastatic behavior.
Researchers identified GPR107 as a key regulator of COL4 levels in the kidney, finding that reduced GPR107 contributes to harmful COL4 accumulation and kidney damage. Strategies aimed at restoring or enhancing GPR107 function could represent a novel approach to preventing diabetic nephropathy progression.
Researchers developed MSCs with aloe emodin-loaded nanoparticles and IFN-γ pretreatment, which inhibited CD4+T cell activation and reduced inflammation in mouse models. The combination also preserved pancreatic structure and function, holding promise for clinical application.
Macrophages expressing high Spp1 levels are found in emphysema patients and those exposed to cigarette smoke or soot-like particles. This study highlights Spp1 as a crucial mediator of environmental particle pollution-related COPD development, offering potential preventive targets.
Groundbreaking progress in TB vaccine development and therapeutic innovations offer hope to curb the disease's devastating impact, with multi-antigen vaccines and mRNA-based platforms showing promise.
This study identifies H3K14 lactylation as a crucial regulator of endothelial activation during sepsis-induced ARDS, driving ferroptosis and vascular injury. Inhibition of lactate production alleviated EC activation and improved survival rates in septic mice.
The article reviews metabolomics-driven approaches for identifying therapeutic targets in drug discovery, highlighting the challenges and limitations of current methods. Emerging technologies like single-cell metabolomics, artificial intelligence, and mass spectrometry imaging are explored to enhance target discovery.
Cerebral vascular malformations (CVMs) are redefined as genetic and molecular-driven conditions, with innovative diagnostic approaches like next-generation sequencing and non-invasive imaging genomics. Targeted therapies, including MEK inhibitors and mTOR inhibitors, offer effective alternatives to traditional surgical methods.
Researchers use various muscle atrophy models to study pathophysiology and develop treatment strategies. Cellular models allow detailed molecular mechanism studies, while animal models simulate human aging and disease-induced conditions.
Researchers profiled gene features and immunoregulatory ceRNA in ischemic stroke, identifying 11 distinct immune cell-related genes. The expression of HECW2 was positively correlated with specific lncRNAs through miRNAs, suggesting a potential biomarker and therapeutic target.